| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director | Chief Strategy Officer +1 more
2 companies
Patel Sushil is a Chief Executive Officer at Replimune Group, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $5.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2025 | REPL Replimune Group, Inc. | Chief Executive Officer | Sell | 10,000 | $11.13 | $111,300.00 | -2.9% | -28.4% | - | |
| May 20, 2025 | REPL Replimune Group, Inc. | Chief Executive Officer | Sell | 25,105 | $8.06 | $202,346.30 | -6.8% | -42.0% | - | |
| Dec 16, 2024 | REPL Replimune Group, Inc. | Chief Executive Officer | Sell | 10,000 | $12.42 | $124,200.00 | -4.7% | -5.6% | -23.0% | |
| Oct 31, 2024 | RVMD Revolution Medicines, Inc. | Director | Sale+OE | 5,000 | $54.14 | $270,714.50 | -20.0% | -23.5% | +10.0% | |
| Jul 9, 2024 | RVMD Revolution Medicines, Inc. | Director | Sale+OE | 2,155 | $44.00 | $94,820.00 | -9.7% | +7.8% | -12.3% | |
| May 16, 2024 | REPL Replimune Group, Inc. | Chief Executive Officer | Sell | 20,194 | $6.47 | $130,655.18 | -8.7% | +46.7% | +16.8% | |
| Apr 10, 2024 | RVMD Revolution Medicines, Inc. | Director | Sale+OE | 2,155 | $37.00 | $79,735.00 | -12.1% | +20.3% | -7.8% | |
| Jun 13, 2023 | REPL Replimune Group, Inc. | Chief Strategy Officer | Sell | 5,698 | $24.04 | $137,008.27 | -1.9% | -17.9% | -63.4% | |
| May 16, 2023 | REPL Replimune Group, Inc. | Chief Strategy Officer | Sell | 15,575 | $18.05 | $281,128.75 | -9.2% | +6.5% | -63.2% | |
| May 16, 2022 | REPL Replimune Group, Inc. | Chief Commercial Officer | Sell | 10,687 | $14.59 | $155,923.33 | -7.6% | +42.1% | +27.3% |